Hostname: page-component-745bb68f8f-5r2nc Total loading time: 0 Render date: 2025-02-06T07:10:41.010Z Has data issue: false hasContentIssue false

Prediction of heart failure and death in an adult population of Fontan patients

Published online by Cambridge University Press:  30 April 2019

Jan Thorben Sieweke
Affiliation:
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
Arash Haghikia
Affiliation:
Department of Cardiology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany
Christian Riehle
Affiliation:
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
Carolin Klages
Affiliation:
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
Muharrem Akin
Affiliation:
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
Tobias König
Affiliation:
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
Carolin Zwadlo
Affiliation:
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
Jens Treptau
Affiliation:
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
Andreas Schäfer
Affiliation:
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
Johann Bauersachs
Affiliation:
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
Mechthild Westhoff-Bleck*
Affiliation:
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
*
Author for correspondence: Mechthild Westhoff-Bleck, MD, Department of Cardiology and Angiology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany. Tel: +49 511 532 2532; Fax: +49 511 532 9435; E-mail: westhoff-bleck.mechthild@mh-hannover.de
Rights & Permissions [Opens in a new window]

Abstract

Background:

Late Fontan survivors are at high risk to experience heart failure and death. Therefore, the current study sought to investigate the role of non-invasive diagnostics as prognostic markers for failure of the systemic ventricle following Fontan procedure.

Methods:

This monocentric, longitudinal observational study included 60 patients with a median age of 24.5 (19–29) years, who were subjected to cardiac magnetic resonance imaging, echocardiography, cardiopulmonary exercise testing, and blood analysis. The primary endpoint of this study was decompensated heart failure with symptoms at rest, peripheral and/or pulmonary edema, and/or death.

Results:

During a follow-up of 24 months, 5 patients died and 5 patients suffered from decompensated heart failure. Clinical (NYHA class, initial surgery), functional (VO2 peak, ejection fraction, cardiac index), circulating biomarkers (N-terminal pro brain natriuretic peptide), and imaging parameters (end diastolic volume index, end systolic volume index, mass-index, contractility, afterload) were significantly related to the primary endpoint. Multi-variate regression analysis identified afterload as assessed by cardiac magnetic resonance imaging as an independent predictor of the primary endpoint (hazard ratio 1.98, 95% confidence interval 1.19–3.29, p = 0.009).

Conclusion:

We identified distinct parameters of cardiopulmonary exercise testing, cardiac magnetic resonance imaging, and blood testing as markers for future decompensated heart failure and death in patients with Fontan circulation. Importantly, our data also identify increased afterload as an independent predictor for increased morbidity and mortality. This parameter is easy to assess by non-invasive cardiac magnetic resonance imaging. Its modulation may represent a potential therapeutic approach target in these high-risk patients.

Type
Original Article
Copyright
© Cambridge University Press 2019 

In a great variety of complex congenital heart diseases with a single ventricle physiology, the Fontan circulation constitutes the only definitive surgical palliation. The Fontan procedureReference Fontan, Mounicot, Baudet, Simonneau, Gordo and Gouffrant 1 significantly improves the survival rate of these patients and enables an increasing number of the patients to survive until adulthood.Reference de Leval, Kilner, Gewillig and Bull 2 Fontan patients represent a heterogeneous population based on the underlying disease, specific type of Fontan procedure, and age at total cavopulmonary connection.

Despite recent advances in surgical techniques, Fontan patients exhibit the highest 5-years risk of death across the heterogeneous group of adults with congenital heart disease.Reference Diller, Kempny and Alonso-Gonzalez 3 Additionally, the presence of a palliative Fontan circulation is associated with numerous complications, such as ventricular dysfunction, arrhythmias, thromboembolic events, atrioventricular valve regurgitation, Fontan pathway obstruction, exercise intolerance, protein-losing enteropathy, and sudden cardiac death.Reference Khairy, Fernandes and Mayer 4 Reference Diller, Dimopoulos and Okonko 7 Thus, there is an unmet clinical need to identify and modify risk factors, which may impact the clinical outcome in these patients.

Late Fontan survivors are prone to develop progressive failure of the morphometric single ventricle. Importantly, echocardiographic assessment of ventricular function is technically difficult. It requires special training and may provide a challenge to the examiner. As an advantage, cardiac magnet resonance imaging offers an unrestricted view on the ventricle. However, evaluation of ventricular function requires a standardized protocol, which respects numerous anatomical variations observed in this heterogeneous patient cohort.Reference Glatz, Rome and Small 8

In non-congenital heart disease, the treatment of symptomatic heart failure improves the outcome.Reference Ponikowski, Voors and Anker 9 In patients with Fontan circulation, the impact of ventricular function on heart failure and death and the indication for standard heart failure drug treatment are still a matter of debate. Therefore, the aim of this study was to evaluate the prognostic value of cardiac magnetic resonance imaging parameters, cardiopulmonary exercise testing, severity of valvular regurgitation, and biomarkers in a cohort of adult Fontan patients. The primary endpoint included decompensated heart failure with symptoms at rest, peripheral and/or pulmonary edema, and/or death. The results of our study may help to improve risk stratification and long-term management of patients with Fontan procedure.

Methods

Patient population

This retrospective, longitudinal observational study was conducted in accordance with the Declaration of Helsinki. The study was approved by the local ethics committee of Hannover Medical School (#2449/2014). Patients were recruited by screening the outpatient clinics database for adults with congenital heart disease. The following inclusion criteria were applied: patients with univentricular heart defects following Fontan procedure with total cavopulmonary connection and documentation of previously performed cardiac magnetic resonance imaging and cardiopulmonary exercise testing. All patients had a minimum follow-up of 24 months after cardiac magnetic resonance imaging. Therefore, we considered for the primary endpoint a time period of 24 months following cardiac magnetic resonance imaging for each patient. Demographic data, physical examination, surgical reports, electrocardiogram, and reports on laboratory testing (N-terminal pro brain natriuretic peptide, albumin, gamma-glutamyltransferase, aspartate transaminase, creatinine, glomerular filtration rate) were derived from medical records of the outpatient clinic for adults with congenital heart disease. Echocardiographic examination, cardiopulmonary exercise testing, and cardiac magnetic resonance imaging were performed at Hannover Medical School. Subsequently, cardiac magnetic resonance imaging parameters were determined by one experienced investigator blinded to the patients` outcome data. Atrioventricular valve regurgitation was graded by echocardiography. The patients’ cohort was divided into groups based on the morphologically dominant systemic ventricle.

Clinical follow-up

All patients were enrolled between July 2005 and July 2015 at the outpatient clinic for adults with congenital heart disease at Hannover Medical School, and their status was determined from medical records. The primary endpoint was defined as follows: death and/or decompensated heart failure with symptoms at rest, peripheral, and/or pulmonary edema.

Cardiac magnetic resonance imaging

Cardiac magnetic resonance imaging was performed with a commercially available 1.5 Tesla magnetic resonance system (Avanto; Siemens Healthcare, Erlangen, Germany). Cardiac parameters were investigated by electrocardiographically gated steady-state free precession technique during short inspiratory breath holds. Subsequently, an offline analysis was performed using certified cardiac magnetic resonance imaging evaluation software (CVI 42; Circle Cardiovascular Imaging Inc., Calgary, Alberta, Canada). Volumes were normalized to body surface area. Ventricular function was evaluated in short axis cine magnetic resonance images. Endo- and epicardial contours were manually drawn in a standardized method, both in end-diastole and end-systole. Papillary muscles and trabeculae were excluded from the ventricular mass.

In Fontan patients, afterload and contractility assessed by cardiac magnetic resonance imaging were previously described with the following approximations: contractility = mean arterial pressure/end-systolic volume index and afterload = mean arterial pressure/cardiac index.Reference Robbers-Visser, Jan Ten Harkel and Kapusta 10 , Reference Bossers, Kapusta and Kuipers 11 Afterload determined by cardiac magnetic resonance imaging is defined as mean arterial pressure/cardiac index, whereas cardiac index is defined as cardiac output indexed to body surface area. Cardiac output was determined by the multiplication of stroke volume and heart rate. Stroke volume and end-systolic volume was evaluated in short axis cine images. Therefore, a potential limitation of this protocol is the quality of the images obtained and the subsequent identification of endo- and epicardial contours.

Echocardiography

All patients were subjected to transthoracic echocardiography (iE33 or EPIQ 7 echocardiography system, Philips Medical Systems, Bothell, Washington). Echocardiographic examination was performed during brief breath hold. Evaluation of left atrial size and left ventricular geometry and function was performed according to the American Society of Echocardiography guidelines.Reference Cheitlin, Armstrong and Aurigemma 12 Conventional doppler echocardiography was used to determine regurgitation of the atrio-ventricular valve.

Cardiopulmonary exercise testing

Cardiopulmonary exercise testing was performed on an electronically braked ergometer cycle using an incremental protocol. The protocol was symptom limited, and all patients were encouraged to exercise until the development of first signs of exhaustion. Twelve-lead electrocardiogram and transcutaneous oxygen saturation were continuously recorded. Ventilatory parameters were measured using a computerized analyzer. In accordance with previous publications, peak VO2 was expressed as percentage of the predicted value using standard equations for predicted values of peak exercise parameters. 13 , Reference Diller, Giardini and Dimopoulos 14

Statistical analysis

Categorical variables are presented as n(%). Normally distributed variables are presented as mean value ± standard deviation (SD) or median and interquartile range (IQR) for non-normally distributed variables. Statistical analysis for comparison between subgroups was performed using unpaired t-tests as parametric tests and Mann–Whitney tests as non-parametric tests.

Chi-square test was applied to compare the patient characteristics. Cardiac magnetic resonance imaging parameters, parameters of cardiopulmonary exercise testing, electrocardiogram-findings, and echocardiographic parameters related to mortality or symptomatic heart failure were identified by Cox regression analysis. Multi-variate regression analysis was performed using variables related to endpoints, which were identified by univariate Cox regression analysis (p < 0.05). Ejection fraction represents a function of both endsystolic and enddiastolic function. Therefore, these parameters were excluded from the multi-variate analysis performed. The cut-off value for afterload was generated from receiver operating characteristic curves using Youden`s Index. Meier–Kaplan curves were created with GraphPad Prism 6.0 (GraphPad Software, Inc., La Jolla, CA), and statistical analysis was performed with SPSS Statistics 24 (IBM SPSS Statistics 24). A two-sided p-value of <0.05 was considered statistically significant.

Results

Baseline characteristics

A total of 60 patients with a mean follow-up of 62 ± 34 months, who visited the outpatient clinic for adults with congenital heart disease between July 2005 and July 2015, were eligible for the study. The patients had a median age of 24.5 years [19–29] and 11 (18%) were women. Cardiac magnetic resonance imaging analysis showed that total cavopulmonary connection was realized with an intra-atrial lateral tunnel in 48 (80%) patients or with an extracardiac conduit in 12 (20%) patients. A morphologic dominant left ventricle (n = 44, 73%) was most frequent. At baseline, all patients had stable symptoms of heart failure (NYHA I n = 21 (35%), NYHA II n = 31 (52%), NYHA III n = 8 (13%)). However, none of the patients included in the study was acutely decompensated, i.e., presenting with lower extremity or pulmonary edema. NYHA class was not significantly different in patients with a morphologic dominant left ventricle when compared with patients with a morphologic dominant right ventricle. Baseline characteristics are summarized in Table 1.

Table 1. Patient baseline characteristics, cardiopulmonary exercise testing, cardiac magnetic resonance imaging, and laboratory statistics

AST = aspartate transaminase; AV = atrioventricular; BT-Shunt = Blalock Taussig shunt; BSA = body surface area; Δ = delta; EF = ejection fraction; EDV = end diastolic volume; ESV = endsystolic volume; GGT = gamma-glutamyltransferase; LV= morphologic dominant left ventricle; MAP = mean arterial pressure; RV = morphologic dominant right ventricle; LBBB = left bundle branch block; RBBB = right bundle branch block; NT-proBNP = N-terminal pro brain natriuretic peptide; NYHA = New York Heart Association; PA-Banding= pulmonary artery banding; PCP = partial cavopulmonary connection; SAO2 = arterial oxygen saturation; SV = stroke volume; TCPC = total cavopulmonary connection; V = ventricular; VE/VCO2 slope = ventilator efficiency; VO2 peak = maximum oxygen uptake.

Data are presented as mean ± SD, median [IQR], n/total (%).

*p<0.05, **p<0.01, ***p<0.001

Decompensated heart failure and death

The primary endpoint occurred in 10 (16.7%) patients after a median follow-up of 3 months [1–11]. Five patients died following systolic deterioration of the systemic ventricle and 5 patients suffered from progressive symptomatic heart failure. Neither the type of total cavopulmonary connection nor the morphology of the dominant ventricle affected the outcome. In contrast, complications were associated with alterations in dimension and function of the systemic ventricle, i.e., mass, ejection fraction, and cardiac index assessed with cardiac magnetic resonance imaging (Fig 1a–c). Patients with adverse outcome exhibited significantly impaired contractility and increased afterload (Fig 1d–e). Furthermore, peak VO2, N-terminal probrain natriuretic peptide, and aspartate transaminase serum levels were significantly altered (Table 2). Using multi-variate analyses, only afterload (p = 0.009) was independently associated with the presence of the predefined endpoint (Table 3). A cut-off of <29.6 mmHg/l/min/m2 ruled out complications within 24 months of follow-up (Fig 2).

Figure 1. Cardiac magnetic resonance imaging parameters significantly altered in patients with future occurrence of the primary endpoint. ***p < 0.001.

Figure 2. Afterload cut-off predicting cardiac complications within 24 month of follow-up. ***p < 0.001.

Table 2. Parameters of complication in total group

AV= atrioventricular; CI= cardiac index; ESV= endsystolic volume; MAP= mean arterial pressure; Δ = delta; VO2 peak= maximum oxygen uptake; EF= Ejection fraction; NYHA= New York Heart Association; BT-Shunt= Blalock Taussig shunt; PA-Banding= pulmonary artery banding; NT-proBNP= N-terminal pro brain natriuretic peptide; GGT= gamma-glutamyltransferase; AST= aspartate transaminase; V= ventricular.

Data are presented as mean ± SD, median [IQR], n/total (%).

*p<0.05, **p<0.01, ***p<0.001

Table 3. Regression-analysis for death or heart failure events

CI = cardiac index; EDV = enddiastolic volume; ESV = endsystolic volume; EF = ejection fraction; ESV = end systolic volume; MAP = mean arterial pressure; NT-proBNP = N-terminal pro brain natriuretic peptide; VO2 peak = maximum oxygen uptake.

*p<0.05, **p<0.01, ***p<0.001

Cardiopulmonary exercise testing

Cardiopulmonary exercise testing with an incremental protocol revealed a significant higher resting heart rate in patients with extracardiac conduit in comparison with patients with an intra-atrial lateral tunnel. Resting oxygen saturation was significant lower in patients with morphologic right ventricle. Parameters of cardiopulmonary exercise testing are shown in Table 1.

Cardiac magnetic resonance imaging, echocardiography, and blood testing

Analysis of cardiac magnetic resonance imaging parameters in respect to total cavopulmonary connection techniques revealed no statistical significance between the groups. Furthermore, at baseline, the cardiac magnetic resonance imaging parameters were not significantly different in respect to the morphologically dominant ventricle. The severity of mitral valve regurgitation assessed by echocardiography was not significantly different. Blood testing showed that patients with morphologic right ventricle had significantly higher gamma-glutamyltransferase levels. No statistical significant difference for N-terminal probrain natriuretic peptide and albumin levels was observed. Cardiac magnetic resonance imaging, echocardiography, and laboratory parameters are summarized in Table 1.

Discussion

The current investigation assesses potential parameters to predict death and/or decompensated heart failure in adult Fontan patients. It provides several important observations: (i) total cavopulmonary connection techniques and the morphology of the dominant ventricle were not associated with a worse outcome. (ii) A number of clinical (NYHA class, initial surgery), functional (VO2 peak, ejection fraction, cardiac index), blood-based (N-terminal pro brain natriuretic peptide), and imaging parameters (end diastolic volume index, end systolic volume index, mass-index, contractility, afterload) were significantly related to an increased rate of decompensated heart failure and death. (iii) Cardiac magnetic resonance imaging-based afterload was the only parameter to serve as an independent predictor for death and decompensated heart failure.

The Fontan procedure is a palliative surgical approach for patients with a functional single ventricular circulation. Fontan circulation is associated with several major complications including heart failure and increased mortality.Reference Ohuchi 15 Hemodynamics of patients with chronic heart failure and Fontan circulation are characterized by high central venous pressure, hypoxia, and reduced cardiac output. This can result from an increase in cardiac preload and systemic arterial resistance.Reference Ohuchi 15 Systemic arterial resistance in adult patients with Fontan circulation is associated with increased sympathetic nerve activity and endothelial dysfunction.Reference Lambert, d’Udekem and Cheung 16 In this regard, adult patients with a limited prognosis exhibit elevated plasma levels of norepinephrine and natriuretic peptides.Reference Ohuchi, Yasuda and Miyazaki 17

The cardiovascular system adapts to increased systemic arterial resistance with increased stroke work of cardiomyocytes, which originate afterload

The prognostic value of afterload is supported by the finding of the present study demonstrating cardiac magnetic resonance imaging-based afterload as an independent predictor of death following systolic deterioration of the systemic ventricle or decompensated heart failure.

Importantly, a cut-off value of 29.6 mmHg/l/min/m² (sensitivity 95.5%, specificity 90%) ruled out the incidence of these complications within a follow-up of 24 months (Fig 2).

To evaluate the cardiac performance of Fontan patients, knowledge of pressure-volume relations, in particular ventricular volume, are indispensable. Paying attention to hemodynamic state based on difficulties of measurement of ventricular volume in clinical situations, Tanoue et al.Reference Tanoue, Sese, Ueno, Joh and Hijii 18 described approximations of contractility and afterload measured by conductance catheter. Hence, the authors were enabled to precisely evaluate hemodynamic state of Fontan patients and evaluate the underlying hemodynamic mechanisms of the favorable outcome after staged total cavopulmonary connection techniques in high-risk Fontan candidates.

Cardiac magnetic resonance imaging represents a powerful diagnostic tool for patients with Fontan circulation.Reference Festa, Ait Ali, Bernabei and De Marchi 19 Parameters associated with ventricular dilation in patients with protein loosing enteropathy are independent predictors of future heart transplantation and death in Fontan patients.Reference Rathod, Prakash and Kim 20 In our investigation, end diastolic volume index, end systolic volume index, ejection fraction, cardiac index, mass-index, contractility, and afterload were related to adverse events.

In the clinical follow-up of adults with congenital heart disease, reduced cardiopulmonary exercise testing has been associated with impaired clinical outcome.Reference Warnes, Williams and Bashore 21 This is supported by several studies, which identified specific parameters of cardiopulmonary exercise testing that differ between Fontan patients and patients with biventricular circulation. These parameters are also associated with increased morbidity in Fontan patients.Reference Giardini, Hager, Pace Napoleone and Picchio 22 Reference Driscoll 24 Patients with Fontan circulation frequently exhibit exercise intolerance;Reference Weipert, Koch, Haehnel and Meisner 25 however, young patients with extracardiac conduit might have increased exercise capacity.Reference Bossers, Helbing and Duppen 26 Of note, only limited data on the prognostic impact of cardiopulmonary exercise testing are available. A previous study showed that cardiopulmonary exercise testing parameters are associated with hospitalization of cardiac cause.Reference Diller, Giardini and Dimopoulos 14 In a recently published study of 145 Fontan patients, a predicted decrease of peak VO2 >3%/year was an independent predictor of death or cardiac surgery during a 5 year follow-up.Reference Egbe, Driscoll and Khan 27 In our investigation, predicted peak VO2 was significantly altered in patients with worsening heart failure symptoms or future death. However, cardiopulmonary exercise testing parameters were inferior regarding risk assessment in the present investigation.

In our investigation, N-terminal pro brain natriuretic peptide levels were significantly elevated in patients afflicted with future death and/or decompensated heart failure. N-terminal probrain natriuretic peptide has a prognostic value in congenital heart disease and correlates with ventricular dysfunction.Reference Westhoff-Bleck, Kornau and Haghikia 28 , Reference Law, Keller, Feingold and Boyle 29 However, increased N-terminal probrain natriuretic peptide levels in patients with Fontan-type circulation may also result from both ventricular dysfunction and increased wall stress of in atriopulmonary connection or lateral tunnels.Reference Heck, Muller, Weber and Hager 30

Despite recent improvements in the treatment of late complications, mortality rates of adult patients with Fontan circulation remain high.Reference Diller, Kempny and Alonso-Gonzalez 3 Current American Heart Association guidelines recommend using angiotensin-converting enzyme inhibitors and diuretics for the pharmacological treatment of impaired contractility of the systemic ventricle or heart transplantation in case of severe dysfunction and end-stage heart failure (class IIa, level of evidence: C).Reference Warnes, Williams and Bashore 21 In conclusion, the present study suggests cardiac magnetic resonance imaging-based afterload as a strong and independent predictor of adverse events and indicates the clinical and prognostic value of assessing this parameter in the management of patients with Fontan circulation. It is tempting to speculate that increased afterload might be an important parameter for establishing failure treatment, which also impacts systemic artery resistance. Further studies are required to test this intriguing hypothesis.

Limitations

The present investigation represents a single center longitudinal observational study. Therefore, no control group is available. Although the number of patients was limited due to the rarity of disease, this study includes one of the largest cohorts of adult patients with Fontan palliation reported so far.

Moreover, clinical status influenced the initiation of further diagnostic procedures such as cardiac magnetic resonance imaging. Therefore, a potential selection bias cannot be excluded. Cardiopulmonary exercise testing and echocardiography were performed as a part of routine follow-up of Fontan patients at a tertiary adult congenital heart disease center. It is important to highlight that the included patients represent the positive selection of long-time survivors. These patients are critical to test and verify current diagnostic and therapeutic approaches.

Conclusion

In adult Fontan patients, parameters derived from cardiac magnetic resonance imaging, cardiopulmonary exercise testing, and laboratory examination are associated with decompensated heart failure and/or death. Afterload assessed by cardiac magnetic resonance imaging seems to be a promising parameter to identify patients at risk of heart failure and death. Thereby, afterload may offer additional valuable information in the decision-making process for medical and surgical treatment strategies.

Author ORCIDs

Jan Thorben Sieweke 0000-0003-3215-7734

Financial Support

This research received no specific grant from any funding agency, commercial or not-for-profit sectors.

Author Contributions

J.T.S, A.H., C.R., and C.K. collected analyzed and interpreted data. J.T.S., A.H., C.R., M.A., A.S., J.B., and M.W.-B. wrote the manuscript. All authors revised the manuscript critically. J.B. and M.W.-B. accurately approved the manuscript.

Disclosure

J.T.S., A.H., C.R., C.K., M.A., T.K., C.Z., J.T., A.S., J.B., and M.W-B have no disclosures regarding this article.

Conflict of interest

The authors have no conflict of interest to declare.

References

Fontan, F, Mounicot, FB, Baudet, E, Simonneau, J, Gordo, J, Gouffrant, JM. “Correction” of tricuspid atresia. 2 cases “corrected” using a new surgical technic. Ann Chir Thorac Cardiovasc 1971; 10: 3947.Google ScholarPubMed
de Leval, MR, Kilner, P, Gewillig, M, Bull, C. Total cavopulmonary connection: a logical alternative to atriopulmonary connection for complex fontan operations. experimental studies and early clinical experience. J Thorac Cardiovasc Surg 1988; 96: 682695.Google ScholarPubMed
Diller, GP, Kempny, A, Alonso-Gonzalez, R, et al. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation 2015; 132: 21182125.CrossRefGoogle Scholar
Khairy, P, Fernandes, SM, Mayer, JE Jr, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 2008; 117: 8592.CrossRefGoogle ScholarPubMed
Pundi, KN, Pundi, KN, Johnson, JN, et al. Sudden cardiac death and late arrhythmias after the Fontan operation. Congenit Heart Dis 2017; 12: 1723.CrossRefGoogle ScholarPubMed
Quinton, E, Nightingale, P, Hudsmith, L, et al. Prevalence of atrial tachyarrhythmia in adults after Fontan operation. Heart 2015; 101: 16721677.CrossRefGoogle ScholarPubMed
Diller, GP, Dimopoulos, K, Okonko, D, et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation 2005; 112: 828835.CrossRefGoogle ScholarPubMed
Glatz, AC, Rome, JJ, Small, AJ, et al. Systemic-to-pulmonary collateral flow, as measured by cardiac magnetic resonance imaging, is associated with acute post-Fontan clinical outcomes. Circ Cardiovasc Imaging 2012; 5: 218225.CrossRefGoogle ScholarPubMed
Ponikowski, P, Voors, AA, Anker, SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC). developed with the special contribution of the heart failure association (HFA) of the ESC. Eur J Heart Fail 2016; 18: 891975.CrossRefGoogle Scholar
Robbers-Visser, D, Jan Ten Harkel, D, Kapusta, L, et al. Usefulness of cardiac magnetic resonance imaging combined with low-dose dobutamine stress to detect an abnormal ventricular stress response in children and young adults after Fontan operation at young age. Am J Cardiol 2008; 101: 16571662.CrossRefGoogle Scholar
Bossers, SS, Kapusta, L, Kuipers, IM, et al. Ventricular function and cardiac reserve in contemporary Fontan patients. Int J Cardiol 2015; 196: 7380.CrossRefGoogle ScholarPubMed
Cheitlin, MD, Armstrong, WF, Aurigemma, GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography). Circulation 2003; 108: 11461162.Google Scholar
ASTRAND I. Aerobic work capacity in men and women with special reference to age. Acta Physiol Scand Suppl 1960; 49: 192.Google Scholar
Diller, GP, Giardini, A, Dimopoulos, K, et al. Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients. Eur Heart J 2010; 31: 30733083.CrossRefGoogle ScholarPubMed
Ohuchi, H. Adult patients with Fontan circulation: what we know and how to manage adults with Fontan circulation? J Cardiol 2016; 68: 181189.CrossRefGoogle ScholarPubMed
Lambert, E, d’Udekem, Y, Cheung, M, et al. Sympathetic and vascular dysfunction in adult patients with Fontan circulation. Int J Cardiol 2013; 167: 13331338.CrossRefGoogle ScholarPubMed
Ohuchi, H, Yasuda, K, Miyazaki, A, et al. Comparison of prognostic variables in children and adults with Fontan circulation. Int J Cardiol 2014; 173: 277283.CrossRefGoogle ScholarPubMed
Tanoue, Y, Sese, A, Ueno, Y, Joh, K, Hijii, T. Bidirectional glenn procedure improves the mechanical efficiency of a total cavopulmonary connection in high-risk Fontan candidates. Circulation 2001; 103: 21762180.CrossRefGoogle ScholarPubMed
Festa, P, Ait Ali, L, Bernabei, M, De Marchi, D. The role of magnetic resonance imaging in the evaluation of the functionally single ventricle before and after conversion to the Fontan circulation. Cardiol Young 2005; 15 (Suppl 3): 5156.CrossRefGoogle ScholarPubMed
Rathod, RH, Prakash, A, Kim, YY, et al. Cardiac magnetic resonance parameters predict transplantation-free survival in patients with Fontan circulation. Circ Cardiovasc Imaging 2014; 7: 502509.CrossRefGoogle ScholarPubMed
Warnes, CA, Williams, RG, Bashore, TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American college of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). developed in collaboration with the American Society of Echocardiography, heart rhythm society, international society for adult congenital heart disease, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Am Coll Cardiol 2008; 52: e143263.CrossRefGoogle Scholar
Giardini, A, Hager, A, Pace Napoleone, C, Picchio, FM. Natural history of exercise capacity after the Fontan operation: a longitudinal study. Ann Thorac Surg 2008; 85: 818821.CrossRefGoogle ScholarPubMed
Dimopoulos, K, Okonko, DO, Diller, GP, et al. Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival. Circulation 2006; 113: 27962802.CrossRefGoogle ScholarPubMed
Driscoll, DJ. Cardiorespiratory responses to exercise after the Fontan operation. Circulation 1990; 81: 20162017.CrossRefGoogle ScholarPubMed
Weipert, J, Koch, W, Haehnel, JC, Meisner, H. Exercise capacity and mid-term survival in patients with tricuspid atresia and complex congenital cardiac malformations after modified Fontan-operation. Eur J Cardiothorac Surg 1997; 12: 574580.CrossRefGoogle ScholarPubMed
Bossers, SS, Helbing, WA, Duppen, N, et al. Exercise capacity in children after total cavopulmonary connection: lateral tunnel versus extracardiac conduit technique. J Thorac Cardiovasc Surg 2014; 148: 14901497.CrossRefGoogle ScholarPubMed
Egbe, AC, Driscoll, DJ, Khan, AR, et al. Cardiopulmonary exercise test in adults with prior Fontan operation: the prognostic value of serial testing. Int J Cardiol 2017; 235: 610.CrossRefGoogle ScholarPubMed
Westhoff-Bleck, M, Kornau, F, Haghikia, A, et al. NT-proBNP indicates left ventricular impairment and adverse clinical outcome in patients with tetralogy of fallot and pulmonary regurgitation. Can J Cardiol 2016; 32: 1247.e291247.e36.CrossRefGoogle ScholarPubMed
Law, YM, Keller, BB, Feingold, BM, Boyle, GJ. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am J Cardiol 2005; 95: 474478.CrossRefGoogle ScholarPubMed
Heck, PB, Muller, J, Weber, R, Hager, A. Value of N-terminal pro brain natriuretic peptide levels in different types of Fontan circulation. Eur J Heart Fail 2013; 15: 644649.CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Patient baseline characteristics, cardiopulmonary exercise testing, cardiac magnetic resonance imaging, and laboratory statistics

Figure 1

Figure 1. Cardiac magnetic resonance imaging parameters significantly altered in patients with future occurrence of the primary endpoint. ***p < 0.001.

Figure 2

Figure 2. Afterload cut-off predicting cardiac complications within 24 month of follow-up. ***p < 0.001.

Figure 3

Table 2. Parameters of complication in total group

Figure 4

Table 3. Regression-analysis for death or heart failure events